Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Archives

Dr Amy Prosser

Dr Simon Hirst

Simon is Sygnature’s Founder, Chief Executive Officer and chair of the Board of Directors. He is a medicinal chemist with...
View Article

Dr Paul Clewlow

Paul joined Sygnature in April 2009 as a member of the Board of Directors. He has over 26 years of...
View Article

Dr Jonathan Williams

Jonathan joined the company as a laboratory scientist in November 2004 and was promoted to the Board in October 2008....
View Article

Mrs Victoria Tabiner

Victoria joined Sygnature in September 2010 as Financial Controller. She was promoted to Finance Director in April 2013 and is...
View Article

Mr Kevin Keck

Kevin is a Partner at Phoenix Equity Partners, a leading private equity investor, which specialises in working with dynamic entrepreneurial...
View Article

Mr Barry Robinson

Barry is an Investment Director at Phoenix Equity Partners, a leading private equity investor, which specialises in working with dynamic...
View Article

Dr Stephen Young

Stephen joined Sygnature in January 2016 from Hitgen where he was VP Business Development; establishing several early research collaborations for...
View Article

Dr Emily Eaton

Emily joined Sygnature in July 2012 as an in vitro Bioscientist and was appointed as Business Development Executive in November...
View Article

Dr Filipa Antunes

Filipa Antunes is a member of the Business Development team, a Senior Scientist in DMPK and the head of Discovery...
View Article

Ms Rumyana Topliyska

Rumyana joined Sygnature in September 2017 as Commercial Contracts Manager. Rumyana has extensive experience in providing commercial and contracts management...
View Article

Mr Mark Thomas

Mark has worked for Sygnature since 2009 and was promoted to the role of Director of Human Resources in early...
View Article